Day: February 6, 2024

Drilling intersection includes 1.4 g/t gold over 109 meters, including 3.2 g/t gold over 18 metresFigure 1Plan View of 2023 Butiá Drill Holes Relative to Resource CategoriesFigure 2Cross Section of 2023 Butiá Drill Holes (Looking West) Relative to Resource CategoriesFigure 3Visible Gold (Red Circles) Associated with Pyrite and Galena Veinlets and Disseminations within Episyenite Host Rock at Butiã Gold Deposit. This sample from drillhole 23BT014 spans the interval 245.0 m to 246.0 m and grades 8.4 g/t gold.Figure 4Visible Gold (Red Circles) Associated with Pyrite and Galena Veinlets and Disseminations within Episyenite Host Rock at Butiã Gold Deposit. This sample from drillhole 23BT014 spans the interval 245.0 m to 246.0 m and grades 8.4 g/t gold.Figure 5Visible Gold (Red Circles) Associated...

EDMONTON, Alberta, Feb. 06, 2024 (GLOBE NEWSWIRE) — Melcor Real Estate Investment Trust (“the REIT” – TSX: MR.UN) today announced that Mr. Larry Pollock and Ms. Carolyn Graham have resigned as a trustees of Melcor REIT. In accordance with the REIT’s declaration of trust, the resignations will be effective March 5, 2024 or such earlier date as the Board may determine. Ralph Young, Chairman of the Board of Melcor REIT commented, “On behalf of the Board of Trustees, we thank Mr. Pollock and Ms. Graham for their valued contributions to the board. We wish both Mr. Pollock and Ms. Graham all the best in their future endeavors.” The board is engaged in identifying and evaluating alternatives with respect to new board trustees and board composition and will continue to follow the requirements of the REIT’s declaration of trust. About...

SHANGHAI, China, Feb. 06, 2024 (GLOBE NEWSWIRE) — ECARX Holdings, Inc. (Nasdaq: ECX) (“ECARX”), a global mobility tech provider, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2023, before the U.S. market opens on Wednesday, February 28, 2024. Company management will hold an earnings conference call via live audio webcast to discuss the financial results and will be available to answer questions from analysts and institutional investors. Earnings Conference Call & Webcast Details:Date: Wednesday, February 28, 2024Time: 8:00am ESTWebcast: https://edge.media-server.com/mmc/p/csskvz6t To join the live conference call, please register at https://register.vevent.com/register/BI6210d5b9045a49d98d4d19261b4f1ff7 to receive the conference call details as...

Figure 1Plan view showing location of SB-2023-016 and 2023-031 in relation to the proposed Mustang Mine developmentFigure 2SB-2023-016 cross section showing intersection the BK-9870 and BK veins with previously released hole SB-2023-017AFigure 3SB-2023-031 intersection on the BK-9870 VeinTORONTO, Feb. 06, 2024 (GLOBE NEWSWIRE) — Talisker Resources Ltd. (“Talisker” or the “Company”) (TSX:TSK | OTCQX:TSKFF) is pleased to announce additional high-grade drill results highlighted by 86.50 g/t Au over 1.50 metres within a broader interval of 14.31 g/t over 9.55 metres at its 100% owned flagship Bralorne Gold Project. Key Points:Talisker initiated resource conversion drilling on October 17, 2023 with 15,000 metres of planned drilling. Hole SB-2023-016 intersected 86.50 g/t Au over 1.50 metres within a broader...

WALTHAM, Mass., Feb. 06, 2024 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today announced the appointment of Dawn Pinchasik, M.D., M.S., as Vice President, Clinical Development. Dr. Pinchasik brings to TScan over a decade of experience in clinical development across the pharmaceutical and biotechnology industry. “We are pleased to welcome Dawn to TScan at such an exciting time in the Company’s evolution,” said Debora Barton, M.D., Chief Medical Officer. “Her expertise in cell and gene therapy clinical development and experience with regulatory interactions, most recently at ElevateBio, will be crucial as we advance our clinical-stage pipeline...

VANCOUVER, British Columbia, Feb. 06, 2024 (GLOBE NEWSWIRE) — ATHA Energy Corp. (CSE: SASK) (FRA: X5U) (OTCQB: SASKF) (“ATHA” or the “Company”), holder of the largest uranium exploration portfolio in two of the highest-grade uranium districts in the world, is pleased to announce that it has appointed Suraj Ahuja M.Sc. as Technical Advisor of the Company to bring valuable resource development expertise to ATHA’s unprecedented exploration efforts, effective February 1, 2023. Troy Boisjoli, CEO of ATHA commented, “We are extremely fortunate to welcome Mr. Ahuja, a mineral exploration and resource development veteran who brings decades of knowledge and experience to our team. As ATHA continues to showcase our commitment to developing the next generation of world-class uranium assets, we are confident that Mr. Ahuja’s proven track record...

VANCOUVER, British Columbia, Feb. 06, 2024 (GLOBE NEWSWIRE) — Mirasol Resources Ltd. (TSX-V: MRZ) (OTCPK: MRZLF) (the “Company” or “Mirasol”) is pleased to announce the promotion of the Company’s President, Tim Heenan, to the position of Chief Executive Officer and his appointment to the Board of Directors. Both these appointments are with immediate effect. Patrick Evans, Chair of Mirasol, commented: “Tim Heenan has been an employee of Mirasol since the founding of the Company in 2005 and has served as President since April, 2022. Over the past two years, Tim has led Mirasol’s transition from project generator to a fully-integrated exploration company focused on discoveries at its rich portfolio of copper-gold porphyry and precious metals projects in Chile and Argentina. We congratulate Tim on his promotion to CEO and welcome his...

ATLANTA and LONDON, Feb. 06, 2024 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Arctic Glacier has improved its distribution network efficiency, its fleet performance and the customer experience by using Descartes’ strategic route planning solution to optimize ice distribution from over 100 facilities and 1,000 vehicles to 75,000 customer locations across the U.S. and Canada. “To minimize our operating costs, we need to reset our network multiple times annually because of large demand fluctuations and our aggressive, acquisition-driven growth strategy,” said Elizabeth DiFazio, Director, Routing & Order Scheduling at Arctic Glacier. “The Descartes solution allows us to quickly execute network reroutes, which helps us...

— Vepdegestrant is an investigational PROteolysis Targeting Chimera (PROTAC®) protein degrader designed to target and degrade the estrogen receptor (ER) protein — NEW HAVEN, Conn. and NEW YORK, Feb. 06, 2024 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the investigation of vepdegestrant (ARV-471) for monotherapy in the treatment of adults with estrogen receptor (ER) positive/human growth epidermal growth factor 2 (HER2) negative (ER+/HER2-) locally advanced or metastatic breast cancer previously treated with endocrine-based therapy. Vepdegestrant is a novel oral PROteolysis Targeting Chimera (PROTAC®) ER degrader that is being jointly developed by Arvinas and Pfizer. As described by...